Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:03:02 2026-09-11 am EDT			5-day change	1st Jan Change
2,837.20 ^INR	-0.13%		-4.10%	+14.82%

Aug. 03	GSK India first-quarter profit rises on steady vaccine demand	RE
Aug. 03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	480,639	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	24.25%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	480,639	480,639
Change	-	-18.99%	58.51%	48.08%	-20.64%	24.25%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	41.3x	35.8x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.1x	15.2x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.3x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.3x	10.2x
EV / Revenue	0x	0x	0x	0x	0x	11.3x	10.2x
EV / EBITDA	0x	0x	0x	0x	0x	32.4x	28.2x
EV / EBIT	0x	0x	0x	0x	0x	32.7x	28.1x
EV / FCF	0x	0x	0x	0x	0x	40x	36.5x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.5%	2.74%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.04%	1.04%
EPS ²	100	36.05	34.83	54.76	61.15	68.78	79.18
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	42.9%	37.3%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,568	47,241
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,836	17,070
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,698	17,112
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,654	13,418
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,837.20	2,837.20
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	41.25x	-	-	1.04%	5.03B
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	18.66x	6.27x	15.06x	2.36%	350.98B
Weighted average by Cap.	23.22x	7.72x	17.10x	2.05%